Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Panitch

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1976
Pathogenesis of visna. III. Immune responses to central nervous system antigens in experimental allergic encephalomyelitis and visnaH Panitch, G Petursson, G Georgsson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1976
Pathogenesis of visna. I. Sequential virologic, serologic, and pathologic studiesG Pétursson, N Nathanson, G Georgsson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1976
Pathogenesis of visna. II. Effect of immunosuppression upon early central nervous system lesionsN Nathanson, H Panitch, P A Palsson, et al.
Neurology|April 11, 2007
Intramedullary spinal cord abscess in a healthy womanA Applebee, M Ramundo, B D Kirkpatrick, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 12, 2002
Effect of combined IFNbeta-1a and glatiramer acetate therapy on GA-specific T-cell responses in multiple sclerosisS Dhib-Jalbut, M Chen, K Henschel, et al.
Nature Medicine|October 4, 2000
Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study GroupL Kappos, G Comi, H Panitch, et al.
Journal of Neuroimmunology|November 1, 1982
Immunological studies of scrapie infectionK C Kasper, D P Stites, K A Bowman, et al.
Journal of Neuroimmunology|August 1, 1995
Interferon beta-1b reduces interferon gamma-induced antigen-presenting capacity of human glial and B cellsH Jiang, R Milo, P Swoveland, et al.
Neurology|January 1, 1986
Monoclonal gammopathy and neuropathy: myelin-associated glycoprotein reactivity and clinical characteristicsD A Hafler, D Johnson, J J Kelly, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 30, 1986
Sulfogalactocerebroside and bis-(monoacylglyceryl)-phosphate as activators of spleen glucocerebrosidaseE M Prence, K O Garrett, H Panitch, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1976
Pathogenesis of visna. III. Immune responses to central nervous system antigens in experimental allergic encephalomyelitis and visnaH Panitch, G Petursson, G Georgsson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1976
Pathogenesis of visna. I. Sequential virologic, serologic, and pathologic studiesG Pétursson, N Nathanson, G Georgsson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1976
Pathogenesis of visna. II. Effect of immunosuppression upon early central nervous system lesionsN Nathanson, H Panitch, P A Palsson, et al.
Neurology|April 11, 2007
Intramedullary spinal cord abscess in a healthy womanA Applebee, M Ramundo, B D Kirkpatrick, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 12, 2002
Effect of combined IFNbeta-1a and glatiramer acetate therapy on GA-specific T-cell responses in multiple sclerosisS Dhib-Jalbut, M Chen, K Henschel, et al.
Nature Medicine|October 4, 2000
Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study GroupL Kappos, G Comi, H Panitch, et al.
Journal of Neuroimmunology|November 1, 1982
Immunological studies of scrapie infectionK C Kasper, D P Stites, K A Bowman, et al.
Journal of Neuroimmunology|August 1, 1995
Interferon beta-1b reduces interferon gamma-induced antigen-presenting capacity of human glial and B cellsH Jiang, R Milo, P Swoveland, et al.
Neurology|January 1, 1986
Monoclonal gammopathy and neuropathy: myelin-associated glycoprotein reactivity and clinical characteristicsD A Hafler, D Johnson, J J Kelly, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 30, 1986
Sulfogalactocerebroside and bis-(monoacylglyceryl)-phosphate as activators of spleen glucocerebrosidaseE M Prence, K O Garrett, H Panitch, et al.
Pageof 3